We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare (HCA) Beats on Q2 Earnings, Revises Guidance
Read MoreHide Full Article
HCA Healthcare, Inc. (HCA - Free Report) reported second-quarter 2018 adjusted earnings of $2.29 per share, surpassing the Zacks Consensus Estimate of $2.14 by 7%. Moreover, the bottom line shot up nearly 32% year over year.
The company’s net income per share of $2.31 in the second quarter includes 2 cents gained from the sale of facilities. This upside reflects a substantial 32% year-over-year surge.
Quarterly Details
HCA Healthcare generated revenues of $11.5 billion, beating the Zacks Consensus Estimate of $11.3 billion. The reported figure was up 7.4% from the year-ago period.
Same facility equivalent admissions increased 2.8% year over year while same facility admissions rose 2.7%. Same facility revenue per equivalent admission grew 3.6%.
Expenses increased nearly 8% year over year to $9.3 billion.
Adjusted EBITDA totaled $2.2 billion, up 6.6% year over year.
As of June 30, 2018, HCA operated 178 hospitals and around 1,800 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
Financial Update
As of Jun 30, 2018, the company had cash and cash equivalents of about $868 million, total debt of $33.2 billion and total assets of $37.7 billion.
During the reported quarter, capital expenditures totaled $880 million excluding acquisitions. Cash flows from operating activities were $1.5 billion, up 12.6% year over year.
Dividend and Share Repurchase Update
HCA Healthcare has announced a quarterly cash dividend of 35 cents per share payable Sep 28 to stockholders of record at the close of business on Sep 4.
The company bought back 4.67 million shares for $470 million in the second quarter and has worth $910 million remaining under its current repurchase authorization.
2018 Outlook Updated
The company expects 2018 revenues in the range of $45.5-$46.5 billion besides an adjusted EBIDTA of $$8.65-$8.85 billion, EPS of $9.00-$9.40 and capital expenditures of about $3.5 billion.
UnitedHealth Group Incorporated’s (UNH - Free Report) second-quarter bottom line beat estimates on the back of higher revenues and solid performances by both segments in the last reported quarter.
Centene Inc.’s (CNC - Free Report) second-quarter earnings surpassed estimates, majorly driven by solid revenues and membership growth.
Anthem Inc. came up with an earnings beat in the second quarter, riding on a strong medical cost performance.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
HCA Healthcare (HCA) Beats on Q2 Earnings, Revises Guidance
HCA Healthcare, Inc. (HCA - Free Report) reported second-quarter 2018 adjusted earnings of $2.29 per share, surpassing the Zacks Consensus Estimate of $2.14 by 7%. Moreover, the bottom line shot up nearly 32% year over year.
HCA Healthcare, Inc. Price and EPS Surprise
HCA Healthcare, Inc. Price and EPS Surprise | HCA Healthcare, Inc. Quote
The company’s net income per share of $2.31 in the second quarter includes 2 cents gained from the sale of facilities. This upside reflects a substantial 32% year-over-year surge.
Quarterly Details
HCA Healthcare generated revenues of $11.5 billion, beating the Zacks Consensus Estimate of $11.3 billion. The reported figure was up 7.4% from the year-ago period.
Same facility equivalent admissions increased 2.8% year over year while same facility admissions rose 2.7%. Same facility revenue per equivalent admission grew 3.6%.
Expenses increased nearly 8% year over year to $9.3 billion.
Adjusted EBITDA totaled $2.2 billion, up 6.6% year over year.
As of June 30, 2018, HCA operated 178 hospitals and around 1,800 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
Financial Update
As of Jun 30, 2018, the company had cash and cash equivalents of about $868 million, total debt of $33.2 billion and total assets of $37.7 billion.
During the reported quarter, capital expenditures totaled $880 million excluding acquisitions. Cash flows from operating activities were $1.5 billion, up 12.6% year over year.
Dividend and Share Repurchase Update
HCA Healthcare has announced a quarterly cash dividend of 35 cents per share payable Sep 28 to stockholders of record at the close of business on Sep 4.
The company bought back 4.67 million shares for $470 million in the second quarter and has worth $910 million remaining under its current repurchase authorization.
2018 Outlook Updated
The company expects 2018 revenues in the range of $45.5-$46.5 billion besides an adjusted EBIDTA of $$8.65-$8.85 billion, EPS of $9.00-$9.40 and capital expenditures of about $3.5 billion.
Zacks Rank
HCA Healthcare carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Releases From the Medical Sector
UnitedHealth Group Incorporated’s (UNH - Free Report) second-quarter bottom line beat estimates on the back of higher revenues and solid performances by both segments in the last reported quarter.
Centene Inc.’s (CNC - Free Report) second-quarter earnings surpassed estimates, majorly driven by solid revenues and membership growth.
Anthem Inc. came up with an earnings beat in the second quarter, riding on a strong medical cost performance.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>